Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 361

1.

Pulmonary Artery Hypertension-Specific Therapy Improves Exercise Tolerance and Outcomes in Exercise-Induced Pulmonary Hypertension.

Kusunose K, Yamada H, Nishio S, Hirata Y, Saijo Y, Torii Y, Yamada N, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30622-9. doi: 10.1016/j.jcmg.2019.07.002. [Epub ahead of print] No abstract available.

PMID:
31422131
2.

Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study.

Kitagawa Y, Osumi H, Shinozaki E, Ota Y, Nakayama I, Suzuki T, Wakatsuki T, Ichimura T, Ogura M, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Manag Res. 2019 Jun 25;11:5757-5764. doi: 10.2147/CMAR.S201048. eCollection 2019.

3.

Updated Left Ventricular Diastolic Function Recommendations and Cardiovascular Events in Patients with Heart Failure Hospitalization.

Torii Y, Kusunose K, Yamada H, Nishio S, Hirata Y, Amano R, Yamao M, Zheng R, Saijo Y, Yamada N, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

J Am Soc Echocardiogr. 2019 Aug 1. pii: S0894-7317(19)30771-0. doi: 10.1016/j.echo.2019.06.006. [Epub ahead of print]

PMID:
31378421
4.

Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.

Mitani S, Kadowaki S, Hasegawa H, Wakatsuki T, Hara H, Tajika M, Nishikawa K, Hirao M, Takahari D, Chin K, Muro K.

Int J Clin Oncol. 2019 May 31. doi: 10.1007/s10147-019-01477-z. [Epub ahead of print]

PMID:
31152323
5.

Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.

Takahari D, Chin K, Ishizuka N, Takashima A, Minashi K, Kadowaki S, Nishina T, Nakajima TE, Amagai K, Machida N, Goto M, Taku K, Wakatsuki T, Shoji H, Hironaka S, Boku N, Yamaguchi K.

Gastric Cancer. 2019 May 17. doi: 10.1007/s10120-019-00973-5. [Epub ahead of print]

PMID:
31102009
6.

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.

Suzuki T, Shinozaki E, Osumi H, Nakayama I, Ota Y, Ichimura T, Ogura M, Wakatsuki T, Ooki A, Takahari D, Suenaga M, Chin K, Yamaguchi K.

Cancer Chemother Pharmacol. 2019 Aug;84(2):307-313. doi: 10.1007/s00280-019-03855-w. Epub 2019 May 7.

PMID:
31065729
7.

Lambda-like J wave due to acute myocardial infarction of the diagonal branch.

Yagi S, Ueno R, Sutou K, Wakatsuki T, Yamaguchi K, Saijo Y, Hara T, Ise T, Kusunose K, Bando M, Matsuura T, Tobiume T, Yamada H, Fukuda D, Soeki T, Akaike M, Sata M.

J Med Invest. 2019;66(1.2):185-187. doi: 10.2152/jmi.66.185.

8.

Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.

Osumi H, Shinozaki E, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Takahari D, Ooki A, Suzuki T, Ota Y, Nakayama I, Chin K, Miki Y, Yamaguchi K.

Int J Cancer. 2019 Apr 9. doi: 10.1002/ijc.32320. [Epub ahead of print]

PMID:
30963570
9.

The single-base-pair deletion, MSH2 c.2635-3delC affecting intron 15 splicing can be a cause of Lynch syndrome.

Ito T, Yamaguchi T, Wakatsuki T, Suzuki T, Eguchi H, Okazaki Y, Yamamoto G, Tachikawa T, Kawakami S, Sasaki A, Akagi K, Ishida H.

Jpn J Clin Oncol. 2019 May 1;49(5):477-480. doi: 10.1093/jjco/hyz031.

PMID:
30882153
10.

A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.

Suenaga M, Wakatsuki T, Mashima T, Ogura M, Ichimura T, Shinozaki E, Nakayama I, Osumi H, Ota Y, Takahari D, Chin K, Seimiya H, Yamaguchi K.

Invest New Drugs. 2019 Mar 6. doi: 10.1007/s10637-019-00749-9. [Epub ahead of print]

PMID:
30838483
11.

Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer.

Kobayashi K, Kawakami K, Yokokawa T, Aoyama T, Suzuki K, Wakatsuki T, Suenaga M, Sato H, Sugiyama E, Yamaguchi K, Hama T.

Oncology. 2019;96(4):200-206. doi: 10.1159/000495989. Epub 2019 Feb 14.

PMID:
30763946
12.

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.

Osumi H, Shinozaki E, Takeda Y, Wakatsuki T, Ichimura T, Saiura A, Yamaguchi K, Takahashi S, Noda T, Zembutsu H.

Cancer Med. 2019 Jan;8(1):408-417. doi: 10.1002/cam4.1913. Epub 2018 Dec 21.

13.

Modified FOLFOX6 as a first-line treatment for patients with advanced gastric cancer with massive ascites or inadequate oral intake.

Osumi H, Takahari D, Chin K, Ogura M, Ichimura T, Wakatsuki T, Suzuki T, Ota Y, Nakayama I, Ooki A, Suenaga M, Shinozaki E, Yamaguchi K.

Onco Targets Ther. 2018 Nov 23;11:8301-8307. doi: 10.2147/OTT.S184665. eCollection 2018.

14.

Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):526. doi: 10.1007/s10120-018-0900-4.

15.

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer.

Nakayama I, Chin K, Takahari D, Ogura M, Ichimura T, Wakatsuki T, Osumi H, Ota Y, Suzuki T, Suenaga M, Shinozaki E, Yamaguchi K.

Cancer Manag Res. 2018 Nov 1;10:5283-5290. doi: 10.2147/CMAR.S179219. eCollection 2018.

16.

Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.

Yagi S, Wakatsuki T, Yamamoto N, Chin K, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Shinozaki E, Suenaga M, Fujisaki J, Ishikawa Y, Yamaguchi K, Namikawa K, Horiuchi Y.

Gastric Cancer. 2019 May;22(3):518-525. doi: 10.1007/s10120-018-0887-x. Epub 2018 Oct 17. Erratum in: Gastric Cancer. 2018 Nov 22;:.

17.

Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery.

Greenberg MJ, Daily NJ, Wang A, Conway MK, Wakatsuki T.

Front Cardiovasc Med. 2018 Sep 19;5:120. doi: 10.3389/fcvm.2018.00120. eCollection 2018. Review.

18.

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab.

Ushida Y, Shinozaki E, Chin K, Suenaga M, Takahari D, Ozaka M, Ogura M, Ichimura T, Wakatsuki T, Yamaguchi K.

Case Rep Oncol. 2018 Aug 29;11(2):601-608. doi: 10.1159/000492568. eCollection 2018 May-Aug.

19.

A model for positive feedback control of the transformation of fibroblasts to myofibroblasts.

Elson EL, Qian H, Fee JA, Wakatsuki T.

Prog Biophys Mol Biol. 2019 Jul;144:30-40. doi: 10.1016/j.pbiomolbio.2018.08.004. Epub 2018 Aug 30. Review.

PMID:
30174171
20.

Right Ventricular Function and Beneficial Effects of Cardiac Rehabilitation in Patients With Systolic Chronic Heart Failure.

Kusunose K, Seno H, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Fukuda D, Yagi S, Soeki T, Wakatsuki T, Sata M.

Can J Cardiol. 2018 Oct;34(10):1307-1315. doi: 10.1016/j.cjca.2018.06.003. Epub 2018 Jun 7.

PMID:
30146462
21.

Association of Decreased Docosahexaenoic Acid Level After Statin Therapy and Low Eicosapentaenoic Acid Level with In-Stent Restenosis in Patients with Acute Coronary Syndrome.

Yagi S, Kondo D, Ise T, Fukuda D, Yamaguchi K, Wakatsuki T, Kawabata Y, Ito H, Saijo Y, Seno H, Sutou K, Ueno R, Todoroki T, Kusunose K, Matsuura T, Tobiume T, Yamada H, Soeki T, Shimabukuro M, Aihara KI, Akaike M, Sata M.

J Atheroscler Thromb. 2019 Mar 1;26(3):272-281. doi: 10.5551/jat.44735. Epub 2018 Aug 21.

22.

A clinical application of preload stress echocardiography for predicting future hemodynamic worsening in patients with early-stage heart failure.

Saijo Y, Yamada H, Kusunose K, Bando M, Nishio S, Torii Y, Hirata Y, Seno H, Matsuura T, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Echocardiography. 2018 Oct;35(10):1587-1595. doi: 10.1111/echo.14098. Epub 2018 Jul 13.

PMID:
30005132
23.

Regorafenib-Induced Hand-Foot Skin Reaction Is More Severe on the Feet Than on the Hands.

Nonomiya Y, Yokokawa T, Kawakami K, Kobayashi K, Aoyama T, Takiguchi T, Sugisaki T, Suzuki K, Suenaga M, Wakatsuki T, Yamaguchi K, Sugimoto Y, Hama T.

Oncol Res. 2019 May 7;27(5):551-556. doi: 10.3727/096504018X15291727589740. Epub 2018 Jun 18.

PMID:
29914591
24.

Phase II trial of biweekly cetuximab and irinotecan as third-line therapy for pretreated KRAS exon 2 wild-type colorectal cancer.

Osumi H, Shinozaki E, Mashima T, Wakatsuki T, Suenaga M, Ichimura T, Ogura M, Ota Y, Nakayama I, Takahari D, Chin K, Miki Y, Yamaguchi K.

Cancer Sci. 2018 Aug;109(8):2567-2575. doi: 10.1111/cas.13698. Epub 2018 Jul 13.

25.

Corrigendum to "Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan" [J Infect Chemother 24 (2018) 330-340].

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Nakajima K, Ueda T, Uchino M, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K.

J Infect Chemother. 2018 Jul;24(7):592-595. doi: 10.1016/j.jiac.2018.05.011. No abstract available.

PMID:
29887496
26.

Clinical, Electrocardiographic, and Echocardiographic Parameter Combination Predicts the Onset of Atrial Fibrillation.

Soeki T, Matsuura T, Tobiume T, Bando S, Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2018 Aug 24;82(9):2253-2258. doi: 10.1253/circj.CJ-17-0758. Epub 2018 May 30.

27.

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Oba K, Maeda M, Maimaituxun G, Yamaguchi S, Arasaki O, Fukuda D, Yagi S, Hirata Y, Nishio S, Iwase T, Takao S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Harada M, Masuzaki H, Sata M, Shimabukuro M.

Circ J. 2018 Jun 25;82(7):1778-1787. doi: 10.1253/circj.CJ-18-0021. Epub 2018 May 25.

28.

Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.

Hayashi T, Hikichi M, Yukitake J, Wakatsuki T, Nishio E, Utsumi T, Harada N.

Oncotarget. 2018 May 4;9(34):23451-23461. doi: 10.18632/oncotarget.25217. eCollection 2018 May 4.

29.

Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients.

Kusunose K, Okushi Y, Yamada H, Nishio S, Torii Y, Hirata Y, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ J. 2018 Jul 25;82(8):2103-2110. doi: 10.1253/circj.CJ-18-0017. Epub 2018 Apr 28.

30.

Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Hara T, Phuong PT, Fukuda D, Yamaguchi K, Murata C, Nishimoto S, Yagi S, Kusunose K, Yamada H, Soeki T, Wakatsuki T, Imoto I, Shimabukuro M, Sata M.

Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.

PMID:
29700120
31.

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.

Wakatsuki T, Yamamoto N, Sano T, Chin K, Kawachi H, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, Matsushima T, Suenaga M, Shinozaki E, Hiki N, Ishikawa Y, Yamaguchi K.

J Gastroenterol. 2018 Nov;53(11):1186-1195. doi: 10.1007/s00535-018-1464-0. Epub 2018 Apr 9.

32.

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel.

Fukuda N, Takahari D, Wakatsuki T, Osumi H, Nakayama I, Matsushima T, Ichimura T, Ogura M, Ozaka M, Suenaga M, Shinozaki E, Chin K, Yamaguchi K.

Oncotarget. 2018 Mar 8;9(20):15219-15227. doi: 10.18632/oncotarget.24635. eCollection 2018 Mar 16.

33.

Local Thickness of Epicardial Adipose Tissue Surrounding the Left Anterior Descending Artery Is a Simple Predictor of Coronary Artery Disease - New Prediction Model in Combination With Framingham Risk Score.

Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Takao S, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M.

Circ J. 2018 Apr 25;82(5):1369-1378. doi: 10.1253/circj.CJ-17-1289. Epub 2018 Mar 21.

34.

Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan.

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Nakajima K, Ueda T, Uchino M, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K.

J Infect Chemother. 2018 May;24(5):330-340. doi: 10.1016/j.jiac.2018.02.011. Epub 2018 Mar 16. Erratum in: J Infect Chemother. 2018 Jul;24(7):592-595.

PMID:
29555391
35.

Corrigendum to 'Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015' [J Infect Chemother 23 (2017) 339-348].

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K.

J Infect Chemother. 2018 Feb;24(2):156-157. doi: 10.1016/j.jiac.2017.11.009. Epub 2017 Dec 1. No abstract available.

PMID:
29198428
36.

Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Yagi S, Aihara KI, Kondo T, Kurahashi K, Yoshida S, Endo I, Fukuda D, Nakaya Y, Suwaki KI, Takeji T, Wada T, Salim HM, Hama S, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Tobiume T, Yamada H, Soeki T, Wakatsuki T, Matsuhisa M, Shimabukuro M, Akaike M, Sata M.

Adv Ther. 2018 Jan;35(1):124-134. doi: 10.1007/s12325-017-0639-z. Epub 2017 Nov 28.

PMID:
29185199
37.

Edoxaban improves acute venous thromboembolism while preserving protein C and protein S levels.

Yamazaki H, Yagi S, Torii Y, Amano R, Oomichi Y, Sangawa T, Fukuda D, Kadota M, Ise T, Ueno R, Hara T, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Akaike M, Sata M.

J Cardiol. 2018 Mar;71(3):305-309. doi: 10.1016/j.jjcc.2017.09.009. Epub 2017 Nov 1.

38.

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus.

Yagi S, Hirata Y, Ise T, Kusunose K, Yamada H, Fukuda D, Salim HM, Maimaituxun G, Nishio S, Takagawa Y, Hama S, Matsuura T, Yamaguchi K, Tobiume T, Soeki T, Wakatsuki T, Aihara KI, Akaike M, Shimabukuro M, Sata M.

Diabetol Metab Syndr. 2017 Oct 4;9:78. doi: 10.1186/s13098-017-0275-4. eCollection 2017.

39.

Preload Stress Echocardiography Predicts Outcomes in Patients With Preserved Ejection Fraction and Low-Gradient Aortic Stenosis.

Kusunose K, Yamada H, Nishio S, Torii Y, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Circ Cardiovasc Imaging. 2017 Oct;10(10). pii: e006690. doi: 10.1161/CIRCIMAGING.117.006690.

PMID:
29021259
40.

Calcium Transient Assays for Compound Screening with Human iPSC-derived Cardiomyocytes: Evaluating New Tools.

Daily NJ, Santos R, Vecchi J, Kemanli P, Wakatsuki T.

J Evol Stem Cell Res. 2017;1(2):1-11. doi: 10.14302/issn.2574-4372.jesr-16-1395. Epub 2017 Jan 24.

41.

Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.

Takagawa Y, Yagi S, Ise T, Ishii A, Nishikawa K, Fukuda D, Kusunose K, Matsuura T, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Katoh S, Aihara KI, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):746-751. doi: 10.1536/ihj.16-454. Epub 2017 Sep 30.

42.

Low Serum Levels of Eicosapentaenoic Acid and Docosahexaenoic Acid are Risk Factors for Cardiogenic Syncope in Patients with Brugada Syndrome.

Yagi S, Soeki T, Aihara KI, Fukuda D, Ise T, Kadota M, Bando S, Matsuura T, Tobiume T, Yamaguchi K, Kusunose K, Yamada H, Wakatsuki T, Shimabukuro M, Akaike M, Sata M.

Int Heart J. 2017 Oct 21;58(5):720-723. doi: 10.1536/ihj.16-278. Epub 2017 Sep 30.

43.

A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.

Murahashi S, Takahari D, Wakatsuki T, Fukuda N, Ichimura T, Ogura M, Ozaka M, Shinozaki E, Nakayama I, Matsushima T, Osumi H, Chin K, Yamaguchi K.

Int J Clin Oncol. 2018 Feb;23(1):92-97. doi: 10.1007/s10147-017-1192-0. Epub 2017 Sep 14.

PMID:
28913565
44.

Echocardiographic Epicardial Adipose Tissue Thickness Is Associated with Symptomatic Coronary Vasospasm during Provocative Testing.

Nishio S, Kusunose K, Yamada H, Hirata Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Shimabukuro M, Sata M.

J Am Soc Echocardiogr. 2017 Oct;30(10):1021-1027.e1. doi: 10.1016/j.echo.2017.06.024. Epub 2017 Aug 23.

PMID:
28843368
45.

Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.

Nakayama I, Chin K, Matsushima T, Takahari D, Ogura M, Shinozaki E, Suenaga M, Ozaka M, Wakatsuki T, Ichimura T, Hiroki O, Yamaguchi K.

Int J Clin Oncol. 2017 Dec;22(6):1060-1068. doi: 10.1007/s10147-017-1164-4. Epub 2017 Jul 26.

PMID:
28748355
46.

RV Myocardial Strain During Pre-Load Augmentation Is Associated With Exercise Capacity in Patients With Chronic HF.

Kusunose K, Yamada H, Nishio S, Ishii A, Hirata Y, Seno H, Saijo Y, Ise T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1240-1249. doi: 10.1016/j.jcmg.2017.03.022. Epub 2017 Jul 19.

47.

Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer.

Osumi H, Takahari D, Shinozaki E, Chin K, Ogura M, Wakatsuki T, Ichimura T, Nakayama I, Matsushima T, Yamaguchi K.

Gastric Cancer. 2018 Mar;21(2):267-275. doi: 10.1007/s10120-017-0729-2. Epub 2017 Jun 5.

PMID:
28584889
48.

Plasma brain natriuretic peptide levels are elevated in patients with cancer.

Bando S, Soeki T, Matsuura T, Tobiume T, Ise T, Kusunose K, Yamaguchi K, Yagi S, Fukuda D, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Muguruma N, Takayama T, Kishimoto I, Kangawa K, Sata M.

PLoS One. 2017 Jun 1;12(6):e0178607. doi: 10.1371/journal.pone.0178607. eCollection 2017.

49.

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.

Osumi H, Shinozaki E, Suenaga M, Wakatsuki T, Nakayama I, Matsushima T, Ogura M, Ichimura T, Takahari D, Chin K, Nagasaki T, Konishi T, Akiyoshi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M, Yamaguchi K.

PLoS One. 2017 May 31;12(5):e0176745. doi: 10.1371/journal.pone.0176745. eCollection 2017.

50.

Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).

Kusunose K, Yamada H, Nishio S, Hirata Y, Seno H, Saijo Y, Ise T, Tobiume T, Yamaguchi K, Yagi S, Soeki T, Wakatsuki T, Sata M.

Am J Cardiol. 2017 Jul 15;120(2):315-321. doi: 10.1016/j.amjcard.2017.04.024. Epub 2017 Apr 26.

PMID:
28532772

Supplemental Content

Loading ...
Support Center